CStone presents research data of CS5001 (ROR1 ADC) at the 33rd AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021
SUZHOU, China, Oct. 8, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the data on the preclinical characterization of the potentially global best-in-class drug CS5001(ROR1 ADC) was accepted in a late-breaking abstract (LBA) session as a virtual poster presentation...
Everest Medicines and Providence Therapeutics Jointly Announce Vaccine Development Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant
SHANGHAI and CALGARY, Canada, Dec. 1, 2021 /PRNewswire/ -- Everest Medicines and Providence Therapeutics ("Providence") jointly announced today that the companies have started working on a new version of COVID-19 vaccine specifically targeting the new Omicron variant. Scientists from the two companies have analyzed the sequence of the SARS-CoV-2 Omicron variant, selected viral sequences, and designed plasmid clones....
Transplant Connect to Expand Human Biologics Management Software with Investment from InVita Healthcare Technologies
LOS ANGELES, Jan. 19, 2022 /PRNewswire/ -- Transplant Connect, the world's leading software provider for the donation and transplantation field, is pleased to announce an investment from InVita Healthcare Technologies. InVita provides leading chain of custody software for complex medical environments including blood, plasma, tissue, implant, and forensic DNA. This strategic...
Novotech Completes $255M Private Placement Transaction and $505M Refinancing to Accelerate Implementation of Growth Initiatives
Proceeds from the transactions will provide strong support to Novotech Holdings' organic and inorganic growth strategies SINGAPORE and SYDNEY, Jan. 19, 2022 /PRNewswire/ -- Novotech Health Holdings Pte. Ltd. ("Novotech Holdings" or the "Company") today announced the completion of a financing round of US$760 million (about 1.06 billion AUD) comprising a US$255 million private placement and a US$505...
Happiness Development Announces $6.7 Million Registered Direct Offering To Support Its Auto Business
NANPING, China, March 11, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ: HAPP) an emerging and diversified company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing solutions, and the sales of automobile today announced that it has entered into a securities purchase agreement with certain non-U.S. strategic investors for...
Adagene Announces FDA Clearance to Proceed with Phase 1b/2 Trial of Anti-CTLA-4 ADG126 SAFEbody® in Combination Therapy With Anti-PD-1 Antibody Pembrolizumab
SAN DIEGO and SUZHOU, China, March 16, 2022 /PRNewswire/ -- Adagene Inc. ("Adagene") (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced FDA clearance to proceed with a Phase 1b/2 clinical trial of its anti-CTLA-4 monoclonal antibody (mAb), ADG126, in combination with the anti-PD-1 antibody pembrolizumab. The global trial (ADG126-P001 / KEYNOTE-C98) will...
SeaX Ventures Launches $60 Million Fund II to Help International Startups Expand in Southeast Asia
BANGKOK, April 4, 2022 /PRNewswire/ -- SeaX Ventures (Southeast Asia Exponential Ventures) announced today the close of its second fund to help accelerate the growth of global startups throughout Southeast Asia. The fund is dedicated to investing in companies working on truly transformational opportunities in sectors including blockchain & web3, foodtech, biotech & life science, artificial intelligence, robotics, and...
Holmusk Announces Publication of Seminal Paper on Real-World Evidence (RWE) Platform NeuroBlu
NEW YORK, April 26, 2022 /PRNewswire/ -- Holmusk, a leading global data science and health technology company building the world's largest real-world evidence (RWE) platform for behavioral health, is pleased to share with the scientific community in-depth details about its platform via the publication of a paper in BMJ Open. The publication centers on the dataset available within NeuroBlu,...
WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware
MIDDLETOWN, Del., Aug. 17, 2022 /PRNewswire/ -- WuXi STA, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), is pleased to announce the groundbreaking for its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware. First announced in June 2021, this site will be WuXi STA's second facility in the United States, offering expanded capacity and greater flexibility to meet...
National Institute of Korean Medicine shows a new trend in Korean Medicine in Times Square, New York
Korean wave towards K-medicine, from K-food, K-pop and K-movies SEOUL, South Korea, Nov. 7, 2022 /PRNewswire/ -- The National Development Institute of Korean Medicine (NIKOM) said a promotional video showing the value of Korean Medicine will be played on the electronic display of the Nasdaq building in Times Square, New York on November 11. Promotional video showing the...
